Ad
related to: tamiflu pediatric dosing
Search results
Results From The WOW.Com Content Network
Oseltamivir, sold under the brand name Tamiflu among others, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. [5] Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. [ 6 ]
The flu is always a nasty foe—and it’s particularly vicious this year. According to the U.S. Centers for Disease Control and Prevention (CDC), there have been at least 12 million flu ...
Clark's rule is a medical term referring to a mathematical formula used to calculate the proper dosage of medicine for children aged 2–17 based on the weight of the patient and the appropriate adult dose. [1] The formula was named after Cecil Belfield Clarke (1894–1970), a Barbadian physician who practiced throughout the UK, the West Indies ...
For example, a study published in the June 2009 Issue of Nature Biotechnology emphasized the urgent need for augmentation of oseltamivir (Tamiflu) stockpiles with additional antiviral drugs including zanamivir (Relenza) based on an evaluation of the performance of these drugs in the scenario that the 2009 H1N1 'Swine Flu' neuraminidase (NA ...
In addition, children age 8-19 months who have an increased risk for severe illness should receive a dose before their second RSV season, according to federal health officials.
"Imagine a household with young children where one of the children gets norovirus at day care or school," Russo said. "Mom and dad are taking care of the child − and become low-hanging fruit for ...
Neuraminidase inhibitors (NAIs) are a class of drugs which block the neuraminidase enzyme. They are a commonly used antiviral drug type against influenza. Viral neuraminidases are essential for influenza reproduction, facilitating viral budding from the host cell.
The three FDA-approved neuraminidase antiviral flu drugs available in the United States, recommended by the CDC, include: oseltamivir (Tamiflu), zanamivir (Relenza), and peramivir (Rapivab). [41] Influenza antiviral resistance often results from changes occurring in neuraminidase and hemagglutinin proteins on the viral surface.